Johnny Turner
Physician Assistant · Lubbock, TXNPI 1023074408
Payments from drug & device makers
Across 382 payments — averaging $19.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- AbbVie$802
- GSK$787
- Bayer$667
- Lilly USA, LLC$643
- Mylan Specialty L.p.$569
- plus $3K from 29 others
What the payments were for
- Food & beverage$7,373100%
- Education$300%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 38 | $1,253 |
| AbbVie | 43 | $802 |
| GSK | 54 | $787 |
| Bayer | 29 | $667 |
| Lilly USA, LLC | 58 | $643 |
| Mylan Specialty L.p. | 43 | $569 |
| Amgen(2 entities) | 25 | $491 |
| Novo Nordisk | 13 | $323 |
| Otsuka America Pharmaceutical, Inc. | 11 | $303 |
| Biohaven Pharmaceuticals, Inc. | 9 | $176 |
| ANI Pharmaceuticals, Inc. | 4 | $146 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $134 |
| Smith+Nephew | 1 | $123 |
| Axsome Therapeutics, Inc. | 7 | $122 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $115 |
| Abbott | 1 | $93 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $76 |
| Amarin Pharma, Inc. | 5 | $74 |
| Verona Pharma, Inc. | 4 | $72 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $59 |
| Boehringer Ingelheim | 3 | $45 |
| Lundbeck LLC | 2 | $36 |
| Pfizer | 2 | $34 |
| Astellas Pharma US Inc | 2 | $34 |
| Daiichi Sankyo Inc. | 2 | $31 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| Johnson & Johnson | 1 | $27 |
| Tris Pharma Inc | 1 | $25 |
| Corium, LLC | 1 | $25 |
| Alkermes, Inc. | 1 | $19 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Merck | 1 | $13 |
| Novartis | 1 | $13 |
| Cequr Corporation | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,403 in reported general payments places this provider in the 90th percentile of 8,308 physician assistant providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 44 | $52,762 |
| MounjaroTirzepatide | 34 | $40,188 |
| EliquisApixaban | 26 | $35,137 |
| JardianceEmpagliflozin | 21 | $33,583 |
| FarxigaDapagliflozin Propanediol | 31 | $30,425 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $27,555 |
| JanuviaSitagliptin Phosphate | 26 | $23,898 |
| TrulicityDulaglutide | 13 | $13,481 |
| Methocarbamol | 18 | $13,424 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 16 | $13,251 |
| VascepaIcosapent Ethyl | 25 | $8,823 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $5,180 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 102 | $3,428 |
| Novolog FlexpenInsulin Aspart | 11 | $2,945 |
| NitrofurantoinNitrofurantoin Macrocrystal | 27 | $2,747 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $643 | $54,84459 claims |
| Novo NordiskOzempic | $323 | $52,76244 claims |
| PfizerEliquis | $34 | $35,13726 claims |
| Boehringer IngelheimJardiance | $45 | $33,58321 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $787 | $32,73438 claims |
| AstraZenecaFarxiga | $1,253 | $30,42531 claims |
| MerckJanuvia | $13 | $23,89826 claims |
| ANI Pharmaceuticals, Inc.Valsartan | $146 | $1,42486 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,308 physician assistant providers in Texas.
Other physician assistant in Lubbock
- Heidi JeffreysLubbock$259K
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Anthony DerenciusSan Antonio$507K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.